Cardiovascular Events Clinical Trials

12 recruiting

Cardiovascular Events Trials at a Glance

12 actively recruiting trials for cardiovascular events are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Nanjing, Hangzhou, and Berlin. Lead sponsors running cardiovascular events studies include Chinese University of Hong Kong, Heinrich-Heine University, Duesseldorf, and AstraZeneca.

Browse cardiovascular events trials by phase

Treatments under study

About Cardiovascular Events Clinical Trials

Looking for clinical trials for Cardiovascular Events? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cardiovascular Events trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cardiovascular Events clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting

Tezspire Cardiac Events PASS

Cardiovascular EventsMACE
AstraZeneca16,640 enrolled4 locationsNCT06951867
Recruiting
Not Applicable

Serial Coronary CTA-based Plaque Progression Detection for Management of Coronary Heart Disease

PreventionMajor Adverse Cardiovascular Events (MACE)
Zhang longjiang,MD3,100 enrolled1 locationNCT06843005
Recruiting
Phase 3

Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy

Myocardial Infarction (MI)Cardiovascular EventsPost Polypectomy Bleeding in Antiplatelet Patients
Chinese University of Hong Kong2,514 enrolled1 locationNCT07052799
Recruiting

The CAMAS Study: A Cross-sectional magnetic resonance imaging study on the myocardial effects of long-term anaerobic exercise using structure-function correlation

Long-term anaerobic exerciseCardiovascular Events
The University of Sydney40 enrolled1 locationACTRN12626000308392
Recruiting
Not Applicable

Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography

Coronary Artery DiseaseCardiovascular EventsCT Angiography+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University3,596 enrolled6 locationsNCT06863545
Recruiting

Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell TransplantationCardiovascular EventsTransplant Complication
Peking University People's Hospital10,000 enrolled16 locationsNCT07349498
Recruiting
Not Applicable

PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI

Acute Coronary SyndromeHyperlipidemiasCardiovascular Events+1 more
Nanjing First Hospital, Nanjing Medical University1,212 enrolled1 locationNCT05457582
Recruiting
Phase 3

Colchicine in Chronic Kidney Disease Patients

Chronic Kidney DiseaseCardiovascular Events
Hospital General Universitario Gregorio Marañon744 enrolled1 locationNCT06998862
Recruiting

Tonometry(1) and Duplex Ultrasound(2) to Predict CV Events in to be Treated Patients With an AAA

Abdominal Aortic AneurysmCardiovascular Events
Rijnstate Hospital194 enrolled7 locationsNCT04183426
Recruiting

Evaluation of Vulnerability of Carotid Plaques and Prediction of Cardio-Cerebrovascular Event Using Ultrasonic Imaging

Ischemic StrokeCardiovascular EventsCarotid Plaque
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine600 enrolled1 locationNCT06473272
Recruiting

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years

InfluenzaCardiovascular EventsCommunity-acquired Pneumonia
Kaiser Permanente960,000 enrolled1 locationNCT06029933
Recruiting

Menopause Related Influences on Leukocyte Distribution, Monocyte Function and Platelet Reactivity

MenopauseAcute Myocardial InfarctionCardiovascular Events+1 more
Heinrich-Heine University, Duesseldorf180 enrolled1 locationNCT05985447